鼎康生物
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing 2024-11-12 21:15
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry 2024-03-07 22:00
Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia 2023-10-26 22:49
Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch 2023-09-25 20:15
Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development 2023-09-22 20:15
Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally 2023-06-30 20:15
Chime Biologics Received Commercial Manufacturing License Indicating the Kick-off into the Era of Commercial Production 2022-08-02 20:15
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion 2021-03-26 08:00
Chime Biologics announces Marc Funk as new Board Director 2021-03-22 18:03
1